EICHOR
● Active Not Recruiting
A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Condition: Prostate Cancer · Cardiovascular Disease · Sponsor: McMaster University
About this study
RADICAL PC1 is a prospective cohort study of men with a new diagnosis of prostate cancer. RADICAL PC2 is a randomized, controlled trial of a systematic approach to modifying cardiovascular and lifestyle risk factors in men with a new diagnosis of prostate cancer.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (61)
| Georgia Cancer Center at Augusta University | Augusta, Georgia, United States | — |
| University of Kansas Medical Center | Kansas City, Kansas, United States | — |
| University of Pennsylvania | Philadelphia, Pennsylvania, United States | — |
| UT Southwestern Medical Center | Dallas, Texas, United States | — |
| Westmead Hospital | Westmead, New South Wales, Australia | — |
| Royal Adelaide Hospital | Adelaide, South Australia, Australia | — |
| Flinders Medical Center | Adelaide, South Australia, Australia | — |
| Centro de Pesquisa Clínica do Brasil | Brasília, Federal District, Brazil | — |
| Hospital Felício Rocho | Belo Horizonte, Minas Gerais, Brazil | — |
| Universidade Federal do Triângulo Mineiro | Uberaba, Minas Gerais, Brazil | — |
| Sociedade Hospitalar Angelina Caron | Campina Grande do Sul, Paraná, Brazil | — |
| Nucleo de Pesquisa Clinica Hospital do Rocio | Campo Largo, Paraná, Brazil | — |
+ 49 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03127631